CardioKinetix raises $14,500,000

CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding.  CardioKinetix, Inc. develops technology for the treatment of congestive heart failure. The company offers medical implants that treat ventricular wall motion abnormalities, which occur after an AMI and can progress to end-stage heart failure.